AU3408999A - Glycine transport inhibitors - Google Patents

Glycine transport inhibitors Download PDF

Info

Publication number
AU3408999A
AU3408999A AU34089/99A AU3408999A AU3408999A AU 3408999 A AU3408999 A AU 3408999A AU 34089/99 A AU34089/99 A AU 34089/99A AU 3408999 A AU3408999 A AU 3408999A AU 3408999 A AU3408999 A AU 3408999A
Authority
AU
Australia
Prior art keywords
formula
butyl
bis
fluorophenyl
piperidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34089/99A
Other languages
English (en)
Inventor
Frans Eduard Janssens
Ludo Edmond Josephine Kennis
Walter Herman Maria Louis Luyten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU3408999A publication Critical patent/AU3408999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU34089/99A 1998-03-06 1999-02-26 Glycine transport inhibitors Abandoned AU3408999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98200701 1998-03-06
EP98200701 1998-03-06
PCT/EP1999/001309 WO1999044596A2 (en) 1998-03-06 1999-02-26 Glycine transport inhibitors

Publications (1)

Publication Number Publication Date
AU3408999A true AU3408999A (en) 1999-09-20

Family

ID=8233444

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34089/99A Abandoned AU3408999A (en) 1998-03-06 1999-02-26 Glycine transport inhibitors

Country Status (17)

Country Link
EP (1) EP1059922A2 (xx)
JP (1) JP2002505277A (xx)
KR (1) KR20010032968A (xx)
CN (1) CN1292698A (xx)
AU (1) AU3408999A (xx)
BG (1) BG104685A (xx)
BR (1) BR9907951A (xx)
CA (1) CA2322164A1 (xx)
EE (1) EE200000482A (xx)
HR (1) HRP20000523A2 (xx)
HU (1) HUP0101048A2 (xx)
IL (1) IL138228A0 (xx)
NO (1) NO20004431L (xx)
PL (1) PL343435A1 (xx)
SK (1) SK13082000A3 (xx)
TR (1) TR200002567T2 (xx)
WO (1) WO1999044596A2 (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515392A (en) * 1999-06-28 2004-03-26 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
CA2406652A1 (en) * 2000-04-20 2001-11-01 Nps Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7049343B2 (en) 2000-09-08 2006-05-23 Merck & Co., Inc. Substituted hydrazine derivatives
CA2422044A1 (en) * 2000-09-14 2002-03-21 Gliatech, Inc. Nitrogen-containing compounds and their use as glycine transport inhibitors
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
DK1703909T3 (da) 2003-09-09 2009-06-22 Hoffmann La Roche 1-benzoyl-piperazinderivater som glycinoptagelsesinhibitorer til behandling af psykoser
RU2354653C2 (ru) * 2003-09-09 2009-05-10 Ф.Хоффманн-Ля Рош Аг Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза
WO2005058885A2 (en) * 2003-12-18 2005-06-30 Glaxo Group Limited Piperidine derivatives and their use as glycine transporter inhibitors
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
AU2005313581B2 (en) 2004-12-09 2011-06-09 F. Hoffmann-La Roche Ag Phenyl-piperazin methanone derivatives
KR100883003B1 (ko) * 2004-12-15 2009-02-12 에프. 호프만-라 로슈 아게 알츠하이머병의 치료를 위한 글라이신 수송체1(ｇｌｙｔ-1) 억제제로서 바이- 및 트라이사이클릭 치환된페닐 메탄온
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
BRPI0519744A2 (pt) * 2005-01-06 2009-03-10 Hoffmann La Roche metanonas de fenila substituÍda por sulfanila como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distérbios neurolàgicos e neuropsiquiÁtricos
CA2593463C (en) * 2005-01-07 2013-10-08 F. Hoffmann-La Roche Ag [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
EP1843767B1 (en) 2005-01-18 2009-07-08 F. Hoffmann-Roche AG 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
AU2006208547B2 (en) 2005-01-26 2011-02-10 F. Hoffmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
CA2596636C (en) * 2005-02-07 2016-04-12 F. Hoffmann-La Roche Ag Heterocyclyl substituted phenyl methanones as inhibitors of the glycine transporter 1
CN100341871C (zh) * 2005-06-03 2007-10-10 复旦大学 含哌啶结构的有机硫化合物，制备方法和应用
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
WO2008053352A2 (en) * 2006-11-01 2008-05-08 Purdue Pharma L.P. Phenylpropionamide compounds and the use thereof
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
CA2707305A1 (en) * 2007-12-12 2009-06-18 Amgen Inc. Glycine transporter-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives

Also Published As

Publication number Publication date
KR20010032968A (ko) 2001-04-25
PL343435A1 (en) 2001-08-13
HUP0101048A2 (hu) 2001-10-28
CA2322164A1 (en) 1999-09-10
EE200000482A (et) 2002-02-15
BG104685A (en) 2001-04-30
BR9907951A (pt) 2001-01-30
TR200002567T2 (tr) 2000-11-21
JP2002505277A (ja) 2002-02-19
NO20004431D0 (no) 2000-09-05
SK13082000A3 (sk) 2001-03-12
HRP20000523A2 (en) 2001-02-28
CN1292698A (zh) 2001-04-25
IL138228A0 (en) 2001-10-31
EP1059922A2 (en) 2000-12-20
WO1999044596A3 (en) 2000-02-17
WO1999044596A2 (en) 1999-09-10
NO20004431L (no) 2000-10-30

Similar Documents

Publication Publication Date Title
AU3408999A (en) Glycine transport inhibitors
AU2016299484B2 (en) 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
US6521621B1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
CA2322136A1 (en) Glycine transport inhibitors
EP0855999B1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
US5731309A (en) Substituted heteroalkyleneamine neurokinin antagonists
US5371094A (en) Azaheterocyclylmethyl-chromans for treating axiety
PL207384B1 (pl) Pochodne benzotiazolu, sposób ich wytwarzania, lek i ich zastosowanie do wytwarzania leku
EA023876B1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
JP2008138007A (ja) タキキニン受容体アンタゴニストとしての５−（４−置換−ピペリジニル−１）−３−アリール−ペンタン酸誘導体
KR20060095865A (ko) 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
JP2012530129A (ja) Ｋａｔｉｉ阻害剤としての二環式および三環式化合物
US4990521A (en) 4-(aroylamino)piperidine-butanimide derivatives
DE60024120T2 (de) Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
AU747815B2 (en) Cyclic amide compounds
WO2017042643A1 (en) Fluoroindole derivatives as muscarinic m1 receptor positive allosteric modulators
CA2585857A1 (en) Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
EP4289425A2 (en) Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors
MXPA00008690A (en) Glycine transport inhibitors
EP3713940B1 (en) Substituted azacycles as muscarinic m1 receptor positive allosteric modulators
CZ20003146A3 (cs) Inhibitory přenosu glycinu
CZ20012711A3 (cs) Deriváty kyseliny hydroxamové obsahující alkynylovou skupinu, jejich příprava a jejich pouľití jako inhibitorů metaloproteináz mezibuněčné hmoty (MMP) a inhibitorů enzymu konvertujícího TNF-alfa (TACE)
MXPA00008692A (en) Glycine transport inhibitors
WO2010087761A1 (en) 2-aza-bicyclo[2.2.2]octane compounds and uses thereof

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application